AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2017
Jan 19, 2017
34129_dirs_2017-01-19_31051cee-52d6-451b-bcd7-b6d750ae60ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-01-17
Reporting Person: Koenig Scott (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-17 | Common Stock | M | 79898 | $0.94 | Acquired | 133163 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-17 | Employee stock option (right to buy) | $0.94 | M | 79898 | Disposed | 2017-11-15 | Common Stock (79898.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 703413 | Indirect |
| Common Stock | 167782 | Indirect |
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18